The US Food and Drug Administration (FDA) has cleared pSivida’s Investigational New Drug (IND) application to treat posterior uveitis with injectable sustained-release micro-insert. pSivida can now move to Phase III trials, which will be in addition to the investigator-sponsored trial … Continue reading →

Sarepta Therapeutics is a biotechnology company focused on developing first-in-class RNA-based therapeutics which will improve or even save the lives of people affected by serious, life-threatening rare and infectious diseases. The company’s pipeline of drugs includes its lead program eteplirsen … Continue reading →

BSD Medical recently announced that its BSD-2000 Hyperthermia System has been purchased by the prestigious University of California San Francisco Medical Center. The system will now be available as a treatment option for the center’s patients. One of the top … Continue reading →

MoSys, a pioneer in semiconductor applications delivering fast, intelligent data access for network and communications systems, announced that a subsidiary of the Macnica Group, Macnica Americas, Inc., has been appointed as its new distributor to keep up with MoSys’ expanding … Continue reading →

Novavax is a clinical stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide. The company’s innovative technology platforms use virus-like particles (VLP) and recombinant nanoparticle technology to create geographic-specific vaccine solutions to combat various … Continue reading →

GreeneStone Healthcare, operator of medical and healthcare clinics in Ontario, Canada, today updated on the progress of its Yorkville clinic, which is in its third month of operations, and said that the outpatient program is slated to open in August … Continue reading →